These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33156523)

  • 1. Galectins-1, -3, -7, -8 and -9 as prognostic markers for survival in epithelial ovarian cancer: A systematic review and meta-analysis.
    Pergialiotis V; Papoutsi E; Androutsou A; Tzortzis AS; Frountzas M; Papapanagiotou A; Kontzoglou K
    Int J Gynaecol Obstet; 2021 Mar; 152(3):299-307. PubMed ID: 33156523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients.
    Schulz H; Schmoeckel E; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and prognostic significance of galectins for patients with gastric cancer: A meta-analysis.
    Long B; Yu Z; Zhou H; Ma Z; Ren Y; Zhan H; Li L; Cao H; Jiao Z
    Int J Surg; 2018 Aug; 56():242-249. PubMed ID: 29940258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation Analysis of Genetic Mutations and Galectin Levels in Breast Cancer Patients.
    Markalunas EG; Arnold DH; Funkhouser AT; Martin JC; Shtutman M; Edenfield WJ; Blenda AV
    Genes (Basel); 2024 Jun; 15(6):. PubMed ID: 38927753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum galectin-1 and galectin-3 levels in benign and malignant nodular thyroid disease.
    Saussez S; Glinoer D; Chantrain G; Pattou F; Carnaille B; André S; Gabius HJ; Laurent G
    Thyroid; 2008 Jul; 18(7):705-12. PubMed ID: 18630998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prognostic Value of Circulating Tumor DNA in Ovarian Cancer: A Meta-Analysis.
    Lu Y; Li L
    Technol Cancer Res Treat; 2021; 20():15330338211043784. PubMed ID: 34817271
    [No Abstract]   [Full Text] [Related]  

  • 7. Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases.
    d'Alessandro M; De Vita E; Bergantini L; Mazzei MA; di Valvasone S; Bonizzoli M; Peris A; Sestini P; Bargagli E; Bennett D
    Respir Physiol Neurobiol; 2020 Nov; 282():103546. PubMed ID: 32920057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival in patients with epithelial ovarian cancer: a systematic review and meta-analysis.
    Taliento C; Morciano G; Nero C; Froyman W; Vizzielli G; Pavone M; Salvioli S; Tormen M; Fiorica F; Scutiero G; Scambia G; Giorgi C; Greco P; Pinton P
    Int J Gynecol Cancer; 2024 Jun; 34(6):906-918. PubMed ID: 38658022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and diagnostic significance of galectins in pancreatic cancer: a systematic review and meta-analysis.
    Sun Q; Zhang Y; Liu M; Ye Z; Yu X; Xu X; Qin Y
    Cancer Cell Int; 2019; 19():309. PubMed ID: 31832021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between high galectin expression and poor prognosis in hematologic cancers: a systematic review and meta-analysis.
    Liu H; Dai Q; Li Y; Tang Z; She T
    Hematology; 2023 Dec; 28(1):2227494. PubMed ID: 37343172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9.
    Schulz H; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U; Schmoeckel E
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of galectins expression in patients with hepatic cancer: A meta-analysis.
    Shao Q; He J; Chen Z; Wu C
    Medicine (Baltimore); 2020 Apr; 99(15):e19622. PubMed ID: 32282710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkers.
    Labrie M; De Araujo LOF; Communal L; Mes-Masson AM; St-Pierre Y
    Sci Rep; 2017 Oct; 7(1):13244. PubMed ID: 29038585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications.
    Mohamed RM; Emam A; Abdelfattah MM; Abdel-Mageed AI; Abdelhafeez MA; Helwa R
    World J Surg Oncol; 2022 Sep; 20(1):276. PubMed ID: 36050693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum galectin-1, galectin-3, and galectin-9 are bystander molecules for chronic spontaneous urticaria.
    Zheng L; Shi ZR; Han YF; Luo YJ; Tang ZQ; Tan GZ; Wang L
    Allergy; 2019 Oct; 74(10):1996-1998. PubMed ID: 31006131
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke.
    He XW; Li WL; Li C; Liu P; Shen YG; Zhu M; Jin XP
    Sci Rep; 2017 Jan; 7():40994. PubMed ID: 28112232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Galectin expression in urological cancer. Diagnostic, prognostic and therapeutic potential].
    Waalkes S; Merseburger AS; Simon A; Serth J; Kuczyk MA
    Urologe A; 2010 Mar; 49(3):387-91. PubMed ID: 20238481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer.
    Chen JP; Huang QD; Wan T; Tu H; Gu HF; Cao JY; Liu JH
    J Ovarian Res; 2019 Jul; 12(1):72. PubMed ID: 31362750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum galectins as potential biomarkers of inflammatory bowel diseases.
    Yu TB; Dodd S; Yu LG; Subramanian S
    PLoS One; 2020; 15(1):e0227306. PubMed ID: 31929564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels.
    Sideras K; de Man RA; Harrington SM; Polak WG; Zhou G; Schutz HM; Pedroza-Gonzalez A; Biermann K; Mancham S; Hansen BE; Bart Takkenberg R; van Vuuren AJ; Pan Q; Ijzermans JNM; Sleijfer S; Sprengers D; Dong H; Kwekkeboom J; Bruno MJ
    Sci Rep; 2019 Jul; 9(1):10677. PubMed ID: 31337865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.